Anzeige
Mehr »
Login
Mittwoch, 05.06.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
10 Gründe für ein herausragendes Chance-Risiko-Verhältnis bei dieser Nickel-Aktie
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Übersicht Suchergebnisse zum Thema MOBERG PHARMA

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
08:09The exercise period for Moberg Pharma's warrants of series 2023:1 (TO 2) begins today1
FrSubscription price for Moberg Pharma's warrants of series 2023:1 (TO 2) determined1
24.05.MOBERG PHARMA: The board of directors exercises authorizations to issue and repurchase C-shares, and converts C-shares to common shares1
20.05.MOBERG PHARMA: Terclara is the market leader in Sweden1
14.05.Bulletin from Moberg Pharma's AGM on May 14[th], 20243
07.05.Moberg Pharma AB: Moberg Pharma's interim report January - March 2024319LAUNCH INITIATED IN SWEDEN FIRST QUARTER (JAN-MAR 2024) Net revenue SEK 0.8 million (0) EBITDA SEK -7.6 million (-6.1) Operating profit (EBIT) SEK -7.9 million (-6.7) Profit after tax SEK -6.5...
► Artikel lesen
06.05.MOBERG PHARMA: National approval for MOB-015 in all 13 countries3
12.04.Notice of Annual General Meeting in Moberg Pharma AB (publ)5
08.04.MOBERG PHARMA: Application submitted to include an additional terbinafine supplier6
19.02.MOBERG PHARMA: The Nomination Committee's proposal to the Annual General Meeting 20247
13.02.Moberg Pharma AB: Year-end report 2023114LAUNCH INITIATED IN SWEDEN THE YEAR (JAN-DEC 2023) EBITDA SEK -25.4 million (-17.6) Operating profit (EBIT) SEK -27.5 million (-20.2) Profit after tax SEK -21.1 million (-15.7) Total profit...
► Artikel lesen
07.02.Moberg Pharma: MOB-015 is launched in Sweden under the brand name Terclara- pharmacies report major demand for the new medication515STOCKHOLM, Feb. 7, 2024 /PRNewswire/ -- Moberg Pharma ABs (OMX: MOB) marker partner in Sweden - Allderma AB, a company which specialises in the sale of over-the-counter (OTC) pharmaceuticals...
► Artikel lesen